• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

获得性华法林抵抗与减肥饮食。

Acquired warfarin resistance and weight-reducing diet.

作者信息

Qureshi G D, Reinders T P, Swint J J, Slate M B

出版信息

Arch Intern Med. 1981 Mar;141(4):507-9.

PMID:7212893
Abstract

A frequent cause of acquired warfarin resistance is drug interaction; however, ingestion of large amounts of vitamin K in food may also be an etiologic factor. A 31-year-old woman on a weight-reducing diet showed evidence of resistance to warfarin sodium therapy. On a regimen of 35 mg of oral warfarin sodium daily, prothrombin time was 14 s (control, 12 s). Pharmacokinetic studies did not reveal any evidence of impaired adsorption or increased catabolism of the drug. The half-life of her oral warfarin was 26 hours (normal, 15 to 56 hours). Although end-organ resistance was not studied fully, a change of her vegetable-rich, weight-reducing diet (vitamin K content, 1,277 microgram) to a regular diet (vitamin K content, 360 microgram) resulted in substantial reduction in her warfarin resistance. We conclude that in patients on vegetable-rich, weight-reducing diets, a relative resistance to warfarin may be secondary to their increased dietary intake of vitamin K.

摘要

获得性华法林抵抗的常见原因是药物相互作用;然而,食物中大量摄入维生素K也可能是一个病因。一名31岁正在进行减肥饮食的女性表现出对华法林钠治疗耐药的迹象。在每日口服35毫克华法林钠的治疗方案下,凝血酶原时间为14秒(对照为12秒)。药代动力学研究未发现药物吸收受损或分解代谢增加的任何证据。她口服华法林的半衰期为26小时(正常为15至56小时)。虽然未充分研究终末器官抵抗,但将她富含蔬菜的减肥饮食(维生素K含量为1277微克)改为常规饮食(维生素K含量为360微克)后,她对华法林的耐药性大幅降低。我们得出结论,对于采用富含蔬菜的减肥饮食的患者,对华法林的相对耐药可能继发于其饮食中维生素K摄入量的增加。

相似文献

1
Acquired warfarin resistance and weight-reducing diet.获得性华法林抵抗与减肥饮食。
Arch Intern Med. 1981 Mar;141(4):507-9.
2
Myocardial infarction after diet-induced warfarin resistance.饮食诱导的华法林抵抗后发生心肌梗死
Arch Intern Med. 1984 Oct;144(10):2089-90.
3
Vitamin K intake and sensitivity to warfarin in patients consuming regular diets.正常饮食患者的维生素K摄入量与对华法林的敏感性
Thromb Haemost. 1999 Mar;81(3):396-9.
4
Warfarin resistance: diagnosis and therapeutic alternatives.华法林抵抗:诊断与治疗选择
Pharmacotherapy. 1996 Nov-Dec;16(6):1009-17.
5
[Resistance to vitamin K antagonists. 6 cases].[对维生素K拮抗剂的抵抗。6例]
Ann Med Interne (Paris). 1986;137(5):384-90.
6
Comment: Decreased warfarin effect after initiation of high-protein, low-carbohydrate diets.
Ann Pharmacother. 2005 Jul-Aug;39(7-8):1371-2; author reply 1372. doi: 10.1345/aph.1E454b. Epub 2005 May 31.
7
Low-dose vitamin K to augment anticoagulation control.低剂量维生素K增强抗凝控制。
Pharmacotherapy. 2005 Dec;25(12):1746-51. doi: 10.1592/phco.2005.25.12.1746.
8
Hereditary warfarin resistance. Investigation of a rare phenomenon.遗传性华法林抵抗。一种罕见现象的调查。
Arch Intern Med. 1985 Mar;145(3):499-501.
9
Warfarin cessation before cardiopulmonary bypass: lessons learned from a randomized controlled trial of oral vitamin K.体外循环前停用华法林:口服维生素K随机对照试验的经验教训
Ann Thorac Surg. 2007 Jul;84(1):103-8. doi: 10.1016/j.athoracsur.2007.03.014.
10
Warfarin or acenocoumarol: which is better in the management of oral anticoagulants?华法林还是醋硝香豆素:哪种在口服抗凝剂管理中更优?
Thromb Haemost. 1998 Dec;80(6):899-902.

引用本文的文献

1
Analysis of Factors That Interrupt With INR Control in the First Anticoagulation Clinic Monitoring Jordanian Patients.分析影响约旦首诊抗凝监测患者 INR 控制的中断因素。
Clin Appl Thromb Hemost. 2019 Jan-Dec;25:1076029619870252. doi: 10.1177/1076029619870252.
2
A review of a priori regression models for warfarin maintenance dose prediction.华法林维持剂量预测的先验回归模型综述。
PLoS One. 2014 Dec 12;9(12):e114896. doi: 10.1371/journal.pone.0114896. eCollection 2014.
3
Warfarin and vitamin K intake in the era of pharmacogenetics.
华法林与维生素 K 摄入:药物遗传学时代。
Br J Clin Pharmacol. 2010 Aug;70(2):164-70. doi: 10.1111/j.1365-2125.2010.03672.x.
4
Case studies in anticoagulation management.抗凝管理案例研究
J Thromb Thrombolysis. 2008 Feb;25(1):78-84. doi: 10.1007/s11239-007-0109-6. Epub 2007 Oct 1.
5
Genetic and environmental risk factors for oral anticoagulant overdose.口服抗凝剂过量的遗传和环境风险因素。
Eur J Clin Pharmacol. 2003 Mar;58(11):739-45. doi: 10.1007/s00228-002-0538-2. Epub 2003 Feb 18.
6
Food-drug interactions.食物-药物相互作用
Drugs. 2002;62(10):1481-502. doi: 10.2165/00003495-200262100-00005.
7
Influence of diet and nutritional status on drug metabolism.饮食和营养状况对药物代谢的影响。
Clin Pharmacokinet. 1996 Jul;31(1):47-64. doi: 10.2165/00003088-199631010-00004.
8
Clinically significant drug interactions with the oral anticoagulants.与口服抗凝剂具有临床意义的药物相互作用。
Drug Saf. 1994 May;10(5):381-94. doi: 10.2165/00002018-199410050-00003.
9
Enteral feeds may antagonise warfarin.肠内营养剂可能会对抗华法林的作用。
Br Med J (Clin Res Ed). 1984 Feb 18;288(6416):557. doi: 10.1136/bmj.288.6416.557.
10
In vitro and in vivo studies of the effect of aztreonam on platelet function and coagulation in normal volunteers.氨曲南对正常志愿者血小板功能和凝血影响的体外和体内研究。
Antimicrob Agents Chemother. 1986 Jul;30(1):73-7. doi: 10.1128/AAC.30.1.73.